Structural Studies of PLCepsilon a regulator of cardiac contractility and hypertrophy.
PLCepsilon 心肌收缩力和肥大调节剂的结构研究。
基本信息
- 批准号:10395991
- 负责人:
- 金额:$ 37.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-04-01 至 2024-03-31
- 项目状态:已结题
- 来源:
- 关键词:AdoptedAllosteric RegulationArchitectureBindingBiochemicalBiological AssayC-terminalCalciumCardiacCardiac MyocytesCardiac developmentCardiovascular DiseasesCardiovascular systemCatalytic DomainCause of DeathCell physiologyCellsChemicalsComplexCoupledCryoelectron MicroscopyCytoplasmDataDevelopmentDiglyceridesDiseaseEnzymesExhibitsFamilyFluorescence Resonance Energy TransferFutureG-Protein-Coupled ReceptorsGene ExpressionGenerationsGenesGoalsGuanine Nucleotide Exchange FactorsGuanosine Triphosphate PhosphohydrolasesHeart DiseasesHeart HypertrophyHomeostasisHypertrophyIn VitroLeadLipaseMembraneMolecularMolecular ConformationMolecular WeightMonomeric GTP-Binding ProteinsN-terminalPathologicPharmaceutical PreparationsPhospholipase CPhosphotransferasesPhysiologicalPlayProtein KinaseProtein Kinase CReceptor ActivationReceptor Protein-Tyrosine KinasesRegulationRoentgen RaysRoleSecond Messenger SystemsSignal TransductionSite-Directed MutagenesisStructureTestingTherapeuticUnited StatesValidationVariantX-Ray Crystallographybasecombatdeletion analysisexperimental studyextracellularin vivoinsightmembernovel therapeutic interventionparticlephosphatidylinositol 4-phosphateprotein kinase Drecruitresponsesmall moleculetherapeutic target
项目摘要
ABSTRACT
Phospholipase C (PLC) enzymes, in particular PLCepsilon, are essential for normal cellular function
in the cardiovascular system. There, they generate second messengers in response to extracellular
signals that increase calcium levels and activate protein kinase C. Misregulation of PLCepsilon is
highly deleterious and can lead to maladaptive changes in cardiac contractility, cell remodeling, and
hypertrophy. Consequently, PLCepsilon is tightly regulated both in its activity and its subcellular
localization. Under basal conditions, the enzyme resides in the cytoplasm and exhibits low activity.
Following the activation of G protein-coupled receptors and/or receptor tyrosine kinases, the enzyme
is allosterically activated and translocated to specific membranes through direct interactions with
small molecular weight GTPases. The small GTPase Rap1A activates and translocates PLCepsilon
to the perinuclear membrane where it stimulates protein kinase cascades involved in cardiac
hypertrophy. However, very little is known about the molecular mechanisms that underlie allosteric
activation of PLCepsilon and its localization by Rap1A. The goal of this proposal is to use an array of
structural, functional, and cell-based studies to provide insights into the molecular mechanisms
underlying the normal and pathological functions of PLCepsilon. In the future, our experiments will aid
in the identification of selective chemical probes for this enzyme and facilitate the development of
novel therapeutic approaches to treat cardiovascular disease, the leading cause of death in the
United States and a rapidly growing problem worldwide.
摘要
磷脂酶C(PLC)酶,特别是PLC,是正常细胞功能所必需的
在心血管系统中。在那里,它们产生第二信使,
增加钙水平和激活蛋白激酶C的信号。PLC的误调节
高度有害,可导致心脏收缩力、细胞重塑和
肥厚因此,PLC在其活性和亚细胞水平上都受到严格调控。
本地化在基础条件下,该酶存在于细胞质中并表现出低活性。
在G蛋白偶联受体和/或受体酪氨酸激酶活化后,
被别构激活,并通过直接相互作用转移到特定的膜
小分子量GTP酶。小的GTdR Rap 1A激活并转位PLC
到核周膜,在那里它刺激蛋白激酶级联,参与心脏
肥厚然而,很少有人知道的分子机制,基础变构
PLC的激活及其通过Rap 1A的定位。这个建议的目标是使用一个数组,
结构,功能和细胞为基础的研究,以提供深入的分子机制
潜在的PLC的正常和病理功能。在未来,我们的实验将有助于
在确定这种酶的选择性化学探针,并促进发展,
治疗心血管疾病的新的治疗方法,心血管疾病是世界上主要的死亡原因,
美国和世界范围内迅速增长的问题。
项目成果
期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Structure of phospholipase Cε reveals an integrated RA1 domain and previously unidentified regulatory elements.
磷脂酶 Cβ 的结构揭示了集成的 RA1 结构域和以前未识别的调节元件。
- DOI:10.1038/s42003-020-01178-8
- 发表时间:2020
- 期刊:
- 影响因子:5.9
- 作者:Rugema,NgangoY;Garland-Kuntz,ElisabethE;Sieng,Monita;Muralidharan,Kaushik;VanCamp,MichelleM;O'Neill,Hannah;Mbongo,William;Selvia,ArielleF;Marti,AndreaT;Everly,Amanda;McKenzie,Emmanda;Lyon,AngelineM
- 通讯作者:Lyon,AngelineM
Structure and regulation of phospholipase Cβ and ε at the membrane.
- DOI:10.1016/j.chemphyslip.2021.105050
- 发表时间:2021-03
- 期刊:
- 影响因子:3.4
- 作者:Muralidharan K;Van Camp MM;Lyon AM
- 通讯作者:Lyon AM
Functional and structural characterization of allosteric activation of phospholipase Cε by Rap1A.
RAP1A对磷脂酶Cε的变构激活的功能和结构表征。
- DOI:10.1074/jbc.ra120.015685
- 发表时间:2020-12-04
- 期刊:
- 影响因子:0
- 作者:Sieng M;Selvia AF;Garland-Kuntz EE;Hopkins JB;Fisher IJ;Marti AT;Lyon AM
- 通讯作者:Lyon AM
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Angeline Marie Lyon其他文献
Angeline Marie Lyon的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Angeline Marie Lyon', 18)}}的其他基金
Structural Studies of PLCepsilon a regulator of cardiac contractility and hypertrophy.
PLCepsilon 心肌收缩力和肥大调节剂的结构研究。
- 批准号:
9900052 - 财政年份:2018
- 资助金额:
$ 37.85万 - 项目类别:
相似海外基金
Molecular insights into the allosteric regulation of opioid receptors
阿片受体变构调节的分子见解
- 批准号:
DE240100931 - 财政年份:2024
- 资助金额:
$ 37.85万 - 项目类别:
Discovery Early Career Researcher Award
Allosteric regulation of lysine degradation as a novel pathophysiological mechanism in glutaric aciduria type 1
赖氨酸降解的变构调节作为 1 型戊二酸尿症的一种新的病理生理机制
- 批准号:
10720740 - 财政年份:2023
- 资助金额:
$ 37.85万 - 项目类别:
Elucidating the Mechanism for Allosteric Regulation of SIRT1 through the N-terminal Region
阐明 SIRT1 通过 N 末端区域变构调节的机制
- 批准号:
10627735 - 财政年份:2023
- 资助金额:
$ 37.85万 - 项目类别:
Allosteric Regulation of Actin Capping Protein: Mechanism and Significance
肌动蛋白加帽蛋白的变构调节:机制和意义
- 批准号:
10330809 - 财政年份:2022
- 资助金额:
$ 37.85万 - 项目类别:
Allosteric Regulation of Actin Capping Protein: Mechanism and Significance
肌动蛋白加帽蛋白的变构调节:机制和意义
- 批准号:
10797746 - 财政年份:2022
- 资助金额:
$ 37.85万 - 项目类别:
Structural and functional studies of allosteric regulation of metabolic enzymes
代谢酶变构调节的结构和功能研究
- 批准号:
RGPIN-2020-04281 - 财政年份:2022
- 资助金额:
$ 37.85万 - 项目类别:
Discovery Grants Program - Individual
Allosteric Regulation of Actin Capping Protein: Mechanism and Significance
肌动蛋白加帽蛋白的变构调节:机制和意义
- 批准号:
10552651 - 财政年份:2022
- 资助金额:
$ 37.85万 - 项目类别:
Allosteric regulation of human cystathionine beta-synthase
人胱硫醚β-合酶的变构调节
- 批准号:
10602404 - 财政年份:2022
- 资助金额:
$ 37.85万 - 项目类别:
Allosteric regulation of human cystathionine beta-synthase
人胱硫醚β-合酶的变构调节
- 批准号:
10381000 - 财政年份:2022
- 资助金额:
$ 37.85万 - 项目类别:
Structural basis for allosteric regulation of RyR1
RyR1 变构调节的结构基础
- 批准号:
10366087 - 财政年份:2021
- 资助金额:
$ 37.85万 - 项目类别:














{{item.name}}会员




